Venous Thromboembolism: all 708 studies
Page 7 of 8. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary EmbolismTerminatedNCT01164046Phase 3
- Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric PatientsCompletedNCT01140386
- Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in CancerCompletedNCT01130025Phase 3
- EUropean Pharmacogenetics of AntiCoagulant Therapy - WarfarinCompletedNCT01119300Phase 4
- EUropean Pharmacogenetics of AntiCoagulant Therapy - PhenprocoumonCompletedNCT01119274Phase 4
- EUropean Pharmacogenetics of AntiCoagulant Therapy - AcenocoumarolCompletedNCT01119261Phase 4
- Mortality Due to Malignancy in Patients With Idiopathic Venous ThromboembolismTerminatedNCT01088334
- Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary BypassStatus unknownNCT01072955Phase 3
- Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary BypassStatus unknownNCT01072747Phase 3
- Obstructive Sleep Apnea and Venous ThromboembolismTerminatedNCT01051297
- Venous Thromboembolism in Advanced Gastric Cancer PatientsCompletedNCT01047618
- Xarelto Regulatory Post-Marketing SurveillanceCompletedNCT01029743
- YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical IllnessCompletedNCT01028950Phase 3
- Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With CancerTerminatedNCT00981903Phase 2
- The Swiss Venous Thromboembolism Cohort 65+CompletedNCT00973596
- Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous ThromboembolismCompletedNCT00967304Phase 4
- DULCIS (D-dimer and ULtrasonography in Combination Italian Study)CompletedNCT00954395
- A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryCompletedNCT00942435Phase 3
- Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower ExtremitiesCompletedNCT00937911Phase 3
- Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous ThromboembolismCompletedNCT00937820Phase 3
- Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical PatientsStatus unknownNCT00934167Phase 2/3
- Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal InsufficiencyTerminatedNCT00927602Phase 4
- Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) ScansStatus unknownNCT00925808
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00917254Phase 2/3
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement SurgeryCompletedNCT00913120Phase 2/3
- Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical PatientsWithdrawnNCT00912483Phase 3
- A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement SurgeryCompletedNCT00902928Phase 2/3
- D-Dimer Guided Oral Anticoagulant Treatment (OAT)Status unknownNCT00895505Phase 3
- Venous Thromboembolism in Pregnancy StudyStatus unknownNCT00856076
- Discharge ALERT: Quality Improvement InitiativeCompletedNCT00853463Not applicable
- Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based DosingCompletedNCT00851864Phase 4
- Xarelto for VTE Prophylaxis After Hip or Knee ArthroplastyCompletedNCT00831714
- The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice SettingsCompletedNCT00830570
- Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill PatientsCompletedNCT00810784
- Predicting Bleeding Risk on Anticoagulant Therapy for Venous ThromboembolismCompletedNCT00788736
- Screening for Occult Malignancy in Patients With Idiopathic Venous ThromboembolismCompletedNCT00773448Not applicable
- Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical TechniquesCompletedNCT00755300
- Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant WomenCompletedNCT00745212
- Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)CompletedNCT00740987Phase 3
- Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)CompletedNCT00740493Phase 3
- Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer SurgeryCompletedNCT00723216Phase 3
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture SurgeryCompletedNCT00721760Phase 3
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement SurgeryCompletedNCT00718224Phase 3
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted MobilityTerminatedNCT00714597Phase 3
- Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture SurgeryCompletedNCT00709904Phase 3
- Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral HemorrhageStatus unknownNCT00699465Phase 4
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement SurgeryCompletedNCT00697099Phase 3
- Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic DiseaseCompletedNCT00695942
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing ChemotherapyCompletedNCT00694382Phase 3
- Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous ThrombosisCompletedNCT00689520Phase 4
- Frankfurt Thrombophilia RegistryCompletedNCT00683397
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryCompletedNCT00679588Phase 3
- Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal CancerCompletedNCT00660205
- Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot StudyTerminatedNCT00655122Phase 4
- Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee ReplacementCompletedNCT00641732Phase 2
- Evaluation of Patients With Vena Cava Inferior ThrombosisCompletedNCT00631423
- Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor PatientsCompletedNCT00629447Not applicable
- Retrospective Study to Review Patients at Risk for VTE at Hospital DischargeCompletedNCT00604370
- Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)WithdrawnNCT00541320Phase 2
- Venous Thromboembolism Taskforce Audit ProgramCompletedNCT00535171
- Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.CompletedNCT00511784
- Sleep Apnea and Tromboembolic DiseaseStatus unknownNCT00501358
- Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU PatientsTerminatedNCT00493896Phase 3
- Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung CancerCompletedNCT00476216Phase 1
- Epidemiology of Venous ThromboembolismCompletedNCT00456196
- Statins to Reduce D-dimer Levels in Patients With Venous ThrombosisTerminatedNCT00437892Phase 2
- Thromboprophylaxis in Critically Ill PatientsTerminatedNCT00437697Phase 4
- Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee ReplacementCompletedNCT00408239Phase 2
- An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging StudyCompletedNCT00402467Phase 2
- Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00398905Phase 2
- Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00396786Phase 2
- Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein ThrombosisCompletedNCT00395772Phase 2
- A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth ControlCompletedNCT00377988
- Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.CompletedNCT00361894Phase 3
- Screening for Occult Malignancy in Idiopathic Venous ThromboembolismCompletedNCT00361647Not applicable
- The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With EnoxaparinStatus unknownNCT00354796
- Dose Ranging Study in Elective Total Hip Replacement SurgeryCompletedNCT00338897Phase 2/3
- Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese PatientsCompletedNCT00333021Phase 3
- Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00332020Phase 3
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00331838Phase 2
- Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart AttacksCompletedNCT00331071
- Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to EnoxaparinCompletedNCT00329628Phase 3
- Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative CareTerminatedNCT00303407
- D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of RecurrenceCompletedNCT00266045
- D-dimer to Establish Duration of Anticoagulation After Venous ThromboembolismCompletedNCT00264277Phase 4
- Understanding Risk Factors Involved in Developing a Second Blood Clot.Status unknownNCT00261014
- The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKORStatus unknownNCT00247702Not applicable
- Aspirin for the Prevention of Recurrent Venous ThromboembolismStatus unknownNCT00222677Phase 2/3
- CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)CompletedNCT00219973Phase 3
- The Roles of Tissue Factor in Malignant GliomasCompletedNCT00201903
- Study of IVC Filter Retrieval With the Günther Tulip Vena Cava FilterCompletedNCT00196118Phase 4
- Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung CarcinomaStatus unknownNCT00192829
- Fixed Dose Heparin StudyCompletedNCT00182403Phase 3
- Safety of a Diagnostic Strategy With D-Dimer Testing for PECompletedNCT00182221Phase 3
- Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)TerminatedNCT00149357
- Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour PatientsCompletedNCT00135876Phase 3
- Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)CompletedNCT00119457Phase 2
- PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)CompletedNCT00077805Phase 4
- EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationCompletedNCT00077753Phase 4
- Monitoring Trends in Venous ThromboembolismCompletedNCT00063518